2933.39.41.00/Nicotine Bitartrate Dihydrate/Canada

Nicotine Bitartrate Dihydrate from Canada

Nicotine bitartrate dihydrate is a heterocyclic compound containing a pyridine ring, used primarily as a drug in smoking cessation aids and nicotine replacement therapies. It falls under HTS 2933.39.41.00 as a drug featuring an unfused pyridine ring structure within Chapter 29's scope for chemically defined organic compounds. This classification applies to its pharmaceutical grade purity and medicinal application.

Duty Rate — Canada → United States

100%

Rate breakdown

9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter

9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter

Calculate with your customs value Verify classification with AI

Import Tips

• Provide FDA Drug Master File (DMF) and Certificate of Analysis confirming pharmaceutical purity >99% to avoid reclassification as non-drug

• Include end-use statement specifying medicinal application to qualify under 'drugs' subheading and prevent duty escalation

• Verify pyridine content via NMR spectroscopy documentation, as impurities may shift classification to non-heterocyclic headings